J. H. Leupold

Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers

H. Allgayer, E. Lengyel, I. Asangani, 2005, Clinical Cancer Research.

Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.

H. Allgayer, E. Lengyel, F. Schildberg, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Urokinase receptor, MMP‐1 and MMP‐9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies

H. Allgayer, S. Post, H. Dralle, 2009, International journal of cancer.

Plasminogen Activators and Their Inhibitors in Cancer

H. Allgayer, J. H. Leupold, 2012 .

P53‐induced miR‐30e‐5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1

H. Allgayer, A. Marx, A. Benner, 2017, International journal of cancer.

The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer

H. Allgayer, Mathias Munschauer, M. Schenone, 2020, Nature Communications.

Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer

H. Allgayer, S. Post, R. Kates, 2007, Clinical Cancer Research.

Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

H. Allgayer, N. Colburn, S. Post, 2007, Cancer.